Stay informed with the latest litigation news. Explore now

IP Verse

Bluebird Bio patent opposition analysis

Latest patents of Bluebird Bio opposed by its competitors

Explore Bluebird Bio's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 28, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP4151720
Aug 7, 2024Vcn Enhancer Compositions And Methods Of Using The Same1
EP3689899
Nov 24, 2021Mnd Promoter Chimeric Antigen Receptors1
EP2760994
Sep 15, 2021Compounds For Improved Viral Transduction2
EP3134095
Apr 22, 2020Improved Methods For Manufacturing Adoptive Cell Therapies3
EP3134432
Dec 25, 2019Mnd Promoter Chimeric Antigen Receptors1
EP3269802
Oct 23, 2019Compounds For Improved Viral Transduction2

Top competitors of Bluebird Bio

Top competitors of Bluebird Bio based on patent oppositions.